- AbbVie Ranked #1 in Biotech Sector on the 2022 S&P
Corporate Sustainability Assessment
NORTH
CHICAGO, Ill., Dec. 12,
2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today
announced that for the tenth consecutive year, it has been named to
the Dow Jones Sustainability World Index (DJSI World) and Dow Jones
Sustainability North America Index (DJSI North America).
Additionally, AbbVie achieved the highest score in the biotech
sector on the 2022 S&P Global Corporate Sustainability
Assessment (CSA). Since AbbVie's founding in 2013, the company has
been listed on the DJSI World and DJSI North America every year.
The S&P Global CSA is an annual evaluation of companies'
sustainability practices. Covering more than 10,000 companies
globally and focusing on sustainability criteria that are both
industry-specific and financially material, the results of the CSA
inform inclusion to the DJSI. AbbVie's achievements of receiving
the top score in the biotech sector and inclusion in the DJSI World
and DJSI North America reflect its ongoing commitment to advance
ESG initiatives that contribute to its sustainable growth and
create a positive impact for generations to come.
"As part of being a company built on sustainable practices, we
are committed to taking actions that best serve patients, our
employees, communities and the planet," said Claudia Carravetta, vice president of corporate
responsibility and global philanthropy, AbbVie. "We are proud to be
included on this year's Dow Jones Sustainability World Index and to
have achieved the highest score in the biotech industry."
Across this year's S&P Global CSA, AbbVie received top
scores in the biotech sector in the following nine criterion:
- Environmental Dimension: Environmental Reporting
- Social Dimension: Social Reporting, Human Rights, Human
Capital Development, Talent Attraction & Retention and Access
to Healthcare
- Governance & Economic Dimension: Materiality, Tax
Strategy and Risk & Crisis Management
AbbVie's top CSA ranking in the biotech sector is as of
December 12, 2022. AbbVie shares its
progress and initiatives in its annual ESG Action Report, found
here. Learn more about AbbVie's commitment to ESG and corporate
responsibility at abbvie.com/societal-impact.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology and gastroenterology, in
addition to products and services across its Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us
at www.abbvie.com. Follow @abbvie
on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Media:
Frank
Benenati (847)
938-8745
Frank.Benenati@abbvie.com
|
Investors:
Liz Shea
(847) 935-2211
Liz.Shea@abbvie.com
|
View original
content:https://www.prnewswire.com/news-releases/abbvie-named-to-dow-jones-sustainability-world-index-for-10th-straight-year-301700637.html
SOURCE AbbVie